Related references
Note: Only part of the references are listed.Clinical, biochemical, and genetic features of non-classical 21-hydroxylase deficiency in Japanese children
Kenichi Kashimada et al.
ENDOCRINE JOURNAL (2015)
Nationwide Neonatal Screening for Congenital Adrenal Hyperplasia in Sweden A 26-Year Longitudinal Prospective Population-Based Study
Sebastian Gidlof et al.
JAMA PEDIATRICS (2014)
Efficiency of Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency in Children Born in Mainland France Between 1996 and 2003
Benedicte Coulm et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Comparison of One-Tier and Two-Tier Newborn Screening Metrics for Congenital Adrenal Hyperplasia
Kyriakie Sarafoglou et al.
PEDIATRICS (2012)
Consolidating newborn screening efforts in the Asia Pacific region
Carmencita David Padilla et al.
JOURNAL OF COMMUNITY GENETICS (2012)
The occurrence of neonatal acute respiratory disorders in 21-hydroxylase deficiency
Keisuke Nagasaki et al.
ENDOCRINE JOURNAL (2011)
Preliminary Report on Neonatal Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Chandigarh Experience
Gurjit Kaur et al.
INDIAN JOURNAL OF PEDIATRICS (2010)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Neonatal screening for congenital adrenal hyperplasia
Perrin C. White
NATURE REVIEWS ENDOCRINOLOGY (2009)
Nonclassic adrenal hyperplasia
Phyllis W. Speiser
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Newborn screening in the Asia Pacific region
Carmencita D. Padilla et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Newborn screening for congenital adrenal hyperplasia: Additional steroid profile using liquid chromatography-tandem mass spectrometry
N. Janzen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry
JM Lacey et al.
CLINICAL CHEMISTRY (2004)
High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland
M Steigert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase deficiency
J Simard et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2002)
Newborn screening for congenital adrenal hyperplasia in the Netherlands
HJ Van der Kamp et al.
PEDIATRICS (2001)
Neonatal screening for congenital adrenal hyperplasia:: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants
A Nordenström et al.
PEDIATRICS (2001)
Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency
N Weintrob et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
